Shenzhen Salubris Pharmaceuticals Co., Ltd.


AG·尊龙凯时

International Business

R&D pipeline

Drug pipeline

Therapeutic field
  • project name Indications Pre-clinical IND Phase I Phase II Phase III NDA
Cardiovascular and related
  • Sacubitril Allisartan Calcium (S086) Hypertension
  • Sacubitril Allisartan Calcium (S086) Chronic heart failure
  • Allisartan IsoproxilAmlodipine Besylate Tablets Hypertension
  • Allisartan IsoproxilIndapamide Sustained-release Tablets Hypertension
  • Enarodustat (SAL0951) Renal anemia
  • SAL0104 (FXIa inhibitor) Thrombosis
  • SAL007 (China) Chronic heart failure
  • SAL007 (USA) Chronic heart failure
  • SAL003 (anti-PCSK9) Hypercholesterolemia
Orthopaedics
  • SAL056 (long-acting Teriparatide) Osteoporosis
  • SAL001 (Forteo Biosesimilar) Osteoporosis
  • SAL023(Biosesimilar) Osteoporosis
Metabolism
  • Fotagliptin Diabetes
  • SAL015(GLP.FC fusion protein) Diabetes
  • SAL0112 Diabetes
Oncology
  • SAL008(Bi-specific antibodyFusion protein) Tumor
Others
  • SAL0114 Depressant
  • Small molecule drugs
  • Biological medicine